Sevoflurane induces neurotoxic effects on developing neurons through the WNK1/NKCC1/Ca2+ /Drp-1 signalling pathway

Ya-Fan Bai1, Wen-Jing Li1, Yu-Wei Ji1

  • 1Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Insights

Sevoflurane anesthesia harms brain cells by disrupting the WNK1/NKCC1/Ca2+/Drp-1 pathway, leading to cell death. Inhibiting this pathway may protect against anesthesia-induced neurotoxicity in children.

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Cell Biology

Background:

  • Repeated anesthesia exposure in children poses a risk for cognitive impairment.
  • The precise mechanisms underlying anesthesia-induced neurotoxicity remain unclear.

Purpose of the Study:

  • To investigate the neurotoxic mechanism of sevoflurane anesthesia.
  • To explore the role of the WNK1/NKCC1/Ca2+/Drp-1 signaling pathway in sevoflurane neurotoxicity.

Main Methods:

  • Utilized the HT22 hippocampal neuronal cell line.
  • Treated cells with sevoflurane anesthesia (4.1% for 6 hours).
  • Administered WNK1, CaN, and Drp-1 inhibitors (WNK-463, FK506, Mdivi-1) prior to sevoflurane exposure.

Main Results:

  • Sevoflurane decreased cell viability and increased apoptosis.
  • Inhibitors WNK-463, FK506, and Mdivi-1 alleviated sevoflurane-induced cell damage and apoptosis.
  • Sevoflurane increased WNK1 kinase and NKCC1 protein levels, intracellular calcium, and CaN expression, while decreasing Drp-1 phosphorylation.
  • FK506 pretreatment reduced Drp-1 dephosphorylation.

Conclusions:

  • The WNK1/NKCC1/Ca2+/Drp-1 pathway is crucial in sevoflurane-induced neurotoxicity.
  • Reducing intracellular calcium influx is a potential strategy to mitigate sevoflurane neurotoxicity.

Related Concept Videos

Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
478
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
414
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
179
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
235